From September 17th to 23rd, 2024, we mark National Pharmacovigilance Week, dedicated to building a robust culture of Adverse Drug Reaction (ADR) reporting. During this pivotal week, we aim to reinforce the importance of vigilant monitoring and reporting of drug safety to enhance patient care and outcomes. On the global stage, September 17th is International Patient Safety Day. This day underscores the critical need for accurate early-stage diagnosis to minimize adverse events and ensure patient safety worldwide. Together, these initiatives are foundational to fostering a culture of patient safety wherever healthcare is delivered. Let's resonate the essence of patient safety by being vigilant, proactive, and collaborative—for our patients, for our communities, and for a healthier world. #NationalPharmacovigilanceWeek #InternationalPatientSafetyDay #PatientSafety #ADRReporting #Healthcare #Pharmacovigilance #PatientCare #NPW2024
Adverse drug reactions (ADRs) reporting plays an important role in patient health and safety. Recognizing their importance can enhance the rate and quality of ADR reporting, which helps improve overall healthcare outcomes. This National Pharmacovigilance Week from September 17th to 23rd, we at AbbVie India are dedicated to fostering a culture of ADR reporting. This year’s theme, "Building ADR Reporting Culture for Patient's Safety," highlights the critical role of Pharmacovigilance in safeguarding patient’s health. Let's come together to improve our practices, share valuable insights, and prioritize patient safety. Suresh Pattathil Gopinath Kesavan Natasha Tiwary Moumita Ghosh Marcus Klein Dr Balaji Ugile Anand Kunchanur #Pharmacovigilance #ADRReporting #PatientSafety #HealthcareExcellence #PharmacovigilanceWeek #NPW2024